Management of transfusional chronic iron overload: focus on deferasirox.

Autor: Pilo F, Di Tucci AA, Dessì L, Angelucci E

Publikováno v: Clinical Medicine: Therapeutics; 2009, Issue 1, p735-745, 11p

Social cognition in youth with a first-degree relative with schizophrenia: A systematic scoping review.

Autor: Tucci AA; Institute of Mental Health Research, Royal Ottawa Mental Health Centre, Ottawa, ON, Canada; Department of Psychology, Carleton University, Ottawa, ON, Canada., Schroeder A; Institute of Mental Health Research, Royal Ottawa Mental Health Centre, Ottawa, ON, Canada; Department of Neuroscience, Carleton University, Ottawa, ON, Canada., Noël C; Institute of Mental Health Research, Royal Ottawa Mental Health Centre, Ottawa, ON, Canada., Shvetz C; Institute of Mental Health Research, Royal Ottawa Mental Health Centre, Ottawa, ON, Canada; Department of Neuroscience, Carleton University, Ottawa, ON, Canada., Yee J; Institute of Mental Health Research, Royal Ottawa Mental Health Centre, Ottawa, ON, Canada., Howard AL; Department of Psychology, Carleton University, Ottawa, ON, Canada., Keshavan MS; Department of Psychiatry, Beth Israel Deaconess Medical Center, Massachusetts Mental Health Center Division of Public Psychiatry, Harvard Medical School, Boston, MA, USA., Guimond S; Institute of Mental Health Research, Royal Ottawa Mental Health Centre, Ottawa, ON, Canada; Department of Psychology, Carleton University, Ottawa, ON, Canada; Department of Neuroscience, Carleton University, Ottawa, ON, Canada; Department of Psychoeducation and Psychology, University of Quebec in Outaouais, Gatineau, QC, Canada; Department of Psychiatry, University of Ottawa, Ottawa, ON, Canada. Electronic address: synthia.guimond@uqo.ca.

Publikováno v: Psychiatry research [Psychiatry Res] 2023 May; Vol. 323, pp. 115173. Date of Electronic Publication: 2023 Mar 21.

Overall survival of myelodysplastic syndrome patients after azacitidine discontinuation and applicability of the North American MDS Consortium scoring system in clinical practice.

Autor: Clavio M; Fondazione Italiana Sindromi Mielodisplastiche-ETS, Bologna, Italy.; UO Clinic of Hematology, Department of Internal Medicine, University of Genoa, Ospedale Policlinico San Martino-IRCCS, Genoa, Italy., Crisà E; Fondazione Italiana Sindromi Mielodisplastiche-ETS, Bologna, Italy.; Division of Hematology, Department of Translational Medicine, Università del Piemonte Orientale and Ospedale Maggiore della Carità, Novara, Italy., Miglino M; Fondazione Italiana Sindromi Mielodisplastiche-ETS, Bologna, Italy.; UO Clinic of Hematology, Department of Internal Medicine, University of Genoa, Ospedale Policlinico San Martino-IRCCS, Genoa, Italy., Guolo F; Fondazione Italiana Sindromi Mielodisplastiche-ETS, Bologna, Italy.; UO Clinic of Hematology, Department of Internal Medicine, University of Genoa, Ospedale Policlinico San Martino-IRCCS, Genoa, Italy., Ceccarelli M; Fondazione Italiana Sindromi Mielodisplastiche-ETS, Bologna, Italy.; SCDU Epidemiologia dei Tumori, CPO Piemonte, Turin, Italy., Salvi F; Fondazione Italiana Sindromi Mielodisplastiche-ETS, Bologna, Italy.; UO Hematology, SS Antonio e Biagio Hospital, Alessandria, Italy., Allione B; Fondazione Italiana Sindromi Mielodisplastiche-ETS, Bologna, Italy.; Division of Hematology, AOU Città della Salute e della Scienza di Torino, Turin, Italy., Ferrero D; Fondazione Italiana Sindromi Mielodisplastiche-ETS, Bologna, Italy.; Division of Hematology, University of Turin, AOU Città della Salute e della Scienza, Turin, Italy., Balleari E; Fondazione Italiana Sindromi Mielodisplastiche-ETS, Bologna, Italy.; UO Internal Medicine, Ospedale Policlinico San Martino-IRCCS, Genoa, Italy., Finelli C; Fondazione Italiana Sindromi Mielodisplastiche-ETS, Bologna, Italy.; UO Hematology, AOU Policlinico Sant'Orsola-Malpighi, University of Bologna, Bologna, Italy., Poloni A; Fondazione Italiana Sindromi Mielodisplastiche-ETS, Bologna, Italy.; Hematology, Università Politecnica Marche, AOU Ospedali Riuniti, Ancona, Italy., Selleri C; Fondazione Italiana Sindromi Mielodisplastiche-ETS, Bologna, Italy.; Hematology and Transplant Unit, San Giovanni di Dio e Ruggi d'Aragona University Hospital, Salerno, Italy., Danise P; Fondazione Italiana Sindromi Mielodisplastiche-ETS, Bologna, Italy.; Hematology Laboratory, Umberto I Hospital, Nocera Inferiore, Italy., Cilloni D; Fondazione Italiana Sindromi Mielodisplastiche-ETS, Bologna, Italy.; Department of Clinical and Biological Sciences, University of Turin, San Luigi Hospital, Turin, Italy., Di Tucci AA; Fondazione Italiana Sindromi Mielodisplastiche-ETS, Bologna, Italy.; Divisione di Ematologia, Ospedale Businco, Cagliari, Italy., Cametti G; Fondazione Italiana Sindromi Mielodisplastiche-ETS, Bologna, Italy.; Division of Internal Medicine, ASLTO5, Turin, Italy., Freilone R; Fondazione Italiana Sindromi Mielodisplastiche-ETS, Bologna, Italy.; Servizio di Oncologia ed Ematologia, Ciriè, Italy., Fanin R; Fondazione Italiana Sindromi Mielodisplastiche-ETS, Bologna, Italy.; Clinica Ematologia e Trapianto Midollo Osseo, AOU Santa Maria della Misericordia, Udine, Italy., Bigazzi C; Fondazione Italiana Sindromi Mielodisplastiche-ETS, Bologna, Italy.; UOC di Ematologia, Ospedale Gen. le Prov. le C. G. Mazzoni, Ascoli Piceno, Italy., Zambello R; Fondazione Italiana Sindromi Mielodisplastiche-ETS, Bologna, Italy.; Hematology and Clinical Immunology Branch, Department of Medicine, University of Padua, Padua, Italy., Crugnola M; Fondazione Italiana Sindromi Mielodisplastiche-ETS, Bologna, Italy.; Hematology Unit and BMT Center, Azienda Ospedaliero Universitaria di Parma, Parma, Italy., Oliva EN; Fondazione Italiana Sindromi Mielodisplastiche-ETS, Bologna, Italy.; Hematology Unit, Grande Ospedale Metropolitano Bianchi Melacrino Morelli, Reggio Calabria, Italy., Centurioni R; Fondazione Italiana Sindromi Mielodisplastiche-ETS, Bologna, Italy.; UOS di Ematologia, Ospedale di Civitanova Marche, Costamartina, Italy., Alesiani F; Fondazione Italiana Sindromi Mielodisplastiche-ETS, Bologna, Italy.; Unità Operativa Semplice di Ematologia, Ospedale di San Severino, San Severino Marche, Italy., Catarini M; Fondazione Italiana Sindromi Mielodisplastiche-ETS, Bologna, Italy.; Divisione di Medicina Interna, Ospedale Civile di Macerata, Macerata, Italy., Castelli A; Fondazione Italiana Sindromi Mielodisplastiche-ETS, Bologna, Italy.; Division of Hematology, Ospedale degli Infermi, Biella, Italy., Abbadessa A; Fondazione Italiana Sindromi Mielodisplastiche-ETS, Bologna, Italy.; Onco-Hematology, AORN S. Anna e S. Sebastiano National Hospital, Caserta, Italy., Capalbo SF; Fondazione Italiana Sindromi Mielodisplastiche-ETS, Bologna, Italy.; Hematology Unit, Azienda Ospedaliero-Universitaria Ospedali Riuniti, Foggia, Italy., Musto P; Fondazione Italiana Sindromi Mielodisplastiche-ETS, Bologna, Italy.; Regional Department of Hematology, IRCCS-CROB, Referral Cancer Center of Basilicata, Rionero in Vulture, Italy., Angelucci E; Fondazione Italiana Sindromi Mielodisplastiche-ETS, Bologna, Italy.; Ematologia e Centro Trapianti, IRCCS Ospedale Policlinico San Martino, Genoa, Italy., Santini V; Fondazione Italiana Sindromi Mielodisplastiche-ETS, Bologna, Italy.; MDS Unit, AOU Careggi, Dipartimento di Medicina Sperimentale e Clinica, University of Florence, Florence, Italy.

Publikováno v: Cancer [Cancer] 2021 Jun 15; Vol. 127 (12), pp. 2015-2024. Date of Electronic Publication: 2021 Mar 19.

Patient-reported outcomes enhance the survival prediction of traditional disease risk classifications: An international study in patients with myelodysplastic syndromes.

Autor: Efficace F; Data Center and Health Outcomes Research Unit, Italian Group for Adult Hematologic Diseases (GIMEMA), Rome, Italy., Cottone F; Data Center and Health Outcomes Research Unit, Italian Group for Adult Hematologic Diseases (GIMEMA), Rome, Italy., Abel G; Division of Population Sciences, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts., Niscola P; Hematology Unit, Sant'Eugenio Hospital, Rome, Italy., Gaidano G; Division of Hematology, Department of Translational Medicine, University of Eastern Piedmont, Novara, Italy., Bonnetain F; Methodology and Quality of Life in Oncology Unit, University Hospital of Besançon, Besançon, France.; Platform Quality of Life and Cancer, INSERM 1098, University of Franche-Comté, Besançon, France., Anota A; Methodology and Quality of Life in Oncology Unit, University Hospital of Besançon, Besançon, France.; Platform Quality of Life and Cancer, INSERM 1098, University of Franche-Comté, Besançon, France., Caocci G; Department of Medical Sciences, University of Cagliari, Cagliari, Italy., Cronin A; Division of Population Sciences, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts., Fianchi L; Institute of Hematology, Catholic University of the Sacred Heart, Rome, Italy., Breccia M; Division of Hematology, Department of Cellular Biotechnologies and Hematology, Sapienza University, Rome, Italy., Stauder R; Department of Internal Medicine V (Hematology and Oncology), Innsbruck Medical University, Innsbruck, Austria., Platzbecker U; Department of Medicine I, University Hospital Dresden Carl Gustav Carus, Dresden, Germany., Palumbo GA; UO Ematologia, AOU Policlinico-V Emanuele, Catania, Italy., Luppi M; Department of Hematology, University of Modena, Modena, Italy., Invernizzi R; Department of Internal Medicine, University of Pavia, San Matteo IRCCS Policlinic Foundation, Pavia, Italy., Bergamaschi M; San Martino Clinical Hematology Clinic, Genova, Italy., Borin L; Department of Hematology, San Gerardo Hospital, Monza, Italy., Di Tucci AA; Hematology and Bone Marrow Transplantation Unit, Armando Businco Hospital, Cagliari, Italy., Zhang H; Department of Hematology, Affiliated Hospital of Liaoning University of Traditional Chinese Medicine, Shenyang, China., Sprangers M; Department of Medical Psychology, Academic Medical Center/University of Amsterdam, Amsterdam, the Netherlands., Vignetti M; Data Center and Health Outcomes Research Unit, Italian Group for Adult Hematologic Diseases (GIMEMA), Rome, Italy., Mandelli F; Data Center and Health Outcomes Research Unit, Italian Group for Adult Hematologic Diseases (GIMEMA), Rome, Italy.

Publikováno v: Cancer [Cancer] 2018 Mar 15; Vol. 124 (6), pp. 1251-1259. Date of Electronic Publication: 2017 Dec 12.

Health-related quality of life in transfusion-dependent patients with myelodysplastic syndromes: a prospective study to assess the impact of iron chelation therapy.

Autor: Efficace F; Data Center and Health Outcomes Research Unit, Italian Group for Adult Hematologic Diseases (GIMEMA), Rome, Italy., Santini V; Functional Unit of Haematology, Azienda Ospedaliero Universitaria Careggi, University of Florence, Florence, Italy., La Nasa G; Bone Marrow Transplantation Center, R. Binaghi Hospital, Cagliari, Italy., Cottone F; Data Center and Health Outcomes Research Unit, Italian Group for Adult Hematologic Diseases (GIMEMA), Rome, Italy., Finelli C; Department of Hematology, Policlinico S. Orsola-Malpighi, Bologna, Italy., Borin L; Department of Hematology, San Gerardo Hospital, Monza, Italy., Quaresmini G; Hematology and Bone Marrow Transplant Unit, Azienda Ospedaliera Papa Giovanni XXIII, Bergamo, Italy., Di Tucci AA; Hematology and Bone Marrow Transplantation Unit, Ospedale Oncologico di Riferimento Regionale 'Armando Businco', Cagliari, Italy., Volpe A; Hematology Division, A.O.R.N. San G. Moscati, Avellino, Italy., Cilloni D; Department of Clinical and Biological Sciences, University of Turin, Turin, Italy., Quarta G; Division of Hematology, Ospedale A. Perrino, Brindisi, Italy., Sanpaolo G; Department of Hematology, IRCCS 'Casa Sollievo della Sofferenza' Hospital, San Giovanni Rotondo, Italy., Rivellini F; UO Medicina Interna e Onco-Ematologica P.O. 'Umberto I', Nocera Inferiore, Italy., Salvi F; Department of Hematology, A.O. Nazionale Santi Antonio e Biagio e C. Arrigo, Alessandria, Italy., Molteni A; Department of Hematology, Niguarda Ca' Granda Hospital, Milan, Italy., Voso MT; Department of Hematology, Università Cattolica del Sacro Cuore, Rome, Italy., Alimena G; Department of Hematology, 'Sapienza' University of Rome, Rome, Italy., Fenu S; Department of Hematology, San Giovanni Hospital, Rome, Italy., Mandelli F; Data Center and Health Outcomes Research Unit, Italian Group for Adult Hematologic Diseases (GIMEMA), Rome, Italy., Angelucci E; Hematology and Bone Marrow Transplantation Unit, Ospedale Oncologico di Riferimento Regionale 'Armando Businco', Cagliari, Italy.

Publikováno v: BMJ supportive & palliative care [BMJ Support Palliat Care] 2016 Mar; Vol. 6 (1), pp. 80-8. Date of Electronic Publication: 2014 Sep 09.